NO20031838L - Benzoksazinonderivater, deres fremstilling av anvendelse - Google Patents

Benzoksazinonderivater, deres fremstilling av anvendelse

Info

Publication number
NO20031838L
NO20031838L NO20031838A NO20031838A NO20031838L NO 20031838 L NO20031838 L NO 20031838L NO 20031838 A NO20031838 A NO 20031838A NO 20031838 A NO20031838 A NO 20031838A NO 20031838 L NO20031838 L NO 20031838L
Authority
NO
Norway
Prior art keywords
preparation
benzoxazinone derivatives
benzoxazinone
derivatives
Prior art date
Application number
NO20031838A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031838D0 (no
Inventor
Christopher Norbert Johnson
Harshad Kantilal Rami
Geoffrey Stemp
Kevin Michael Thewlis
Mervyn Thompson
Antonio Kuok Keong Vong
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20031838D0 publication Critical patent/NO20031838D0/no
Publication of NO20031838L publication Critical patent/NO20031838L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031838A 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse NO20031838L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
PCT/EP2001/012344 WO2002034754A2 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO20031838D0 NO20031838D0 (no) 2003-04-24
NO20031838L true NO20031838L (no) 2003-06-24

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031838A NO20031838L (no) 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse

Country Status (20)

Country Link
US (1) US6939871B2 (zh)
EP (1) EP1330460B1 (zh)
JP (1) JP4242643B2 (zh)
KR (1) KR20030051747A (zh)
CN (1) CN1478092A (zh)
AR (1) AR034174A1 (zh)
AT (1) ATE357448T1 (zh)
AU (1) AU2002224791A1 (zh)
BR (1) BR0114881A (zh)
CA (1) CA2426706A1 (zh)
CZ (1) CZ20031163A3 (zh)
DE (1) DE60127434T2 (zh)
ES (1) ES2280417T3 (zh)
HU (1) HUP0301458A2 (zh)
IL (1) IL155520A0 (zh)
MX (1) MXPA03003820A (zh)
NO (1) NO20031838L (zh)
PL (1) PL366378A1 (zh)
TW (1) TWI237023B (zh)
WO (1) WO2002034754A2 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
MXPA05002003A (es) * 2002-09-26 2005-08-03 Warner Lambert Co Piperazinas sustituidas heterociclicas para el tratamiento de la esquizofrenia.
DE50312598D1 (de) 2002-10-10 2010-05-20 Morphochem Ag Komb Chemie Neue verbindungen mit antibakterieller aktivität
CN100390157C (zh) * 2002-11-08 2008-05-28 弗·哈夫曼-拉罗切有限公司 取代的苯并嗪酮及其用途
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
US6987194B2 (en) * 2003-04-30 2006-01-17 Fmc Corporation Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
CA2574737A1 (en) * 2004-07-28 2006-02-09 Irm Llc Compounds and compositions as modulators of steroid hormone nuclear receptors
EP1943222A1 (de) * 2005-10-13 2008-07-16 Morphochem Aktiengesellschaft Für Kombinatorische Chemie 5-chinolinderivate mit antibakterieller aktivität
CA2750047A1 (en) 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
US8927541B2 (en) 2009-12-18 2015-01-06 Basilea Pharmaceutica Ag Tricyclic antibiotics
JP2014517019A (ja) 2011-06-17 2014-07-17 バジリア ファルマスーチカ アーゲー 三環式抗生物質
MD3483164T2 (ro) 2017-03-20 2020-07-31 Forma Therapeutics Inc Compoziții pirolopirolice ca activatori ai piruvat kinazei (PKR)
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191180T3 (es) * 1996-05-29 2003-09-01 Warner Lambert Co Antagonistas de los receptores de la dopamina benzoxazinona d4.
EP0900792B1 (en) 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives

Also Published As

Publication number Publication date
MXPA03003820A (es) 2003-07-28
CA2426706A1 (en) 2002-05-02
ES2280417T3 (es) 2007-09-16
HUP0301458A2 (hu) 2003-10-28
NO20031838D0 (no) 2003-04-24
IL155520A0 (en) 2003-11-23
DE60127434T2 (de) 2007-11-29
WO2002034754A2 (en) 2002-05-02
US6939871B2 (en) 2005-09-06
CN1478092A (zh) 2004-02-25
ATE357448T1 (de) 2007-04-15
DE60127434D1 (de) 2007-05-03
BR0114881A (pt) 2003-09-30
AR034174A1 (es) 2004-02-04
AU2002224791A1 (en) 2002-05-06
TWI237023B (en) 2005-08-01
JP2004516250A (ja) 2004-06-03
PL366378A1 (en) 2005-01-24
CZ20031163A3 (cs) 2004-04-14
EP1330460B1 (en) 2007-03-21
WO2002034754A3 (en) 2002-07-11
US20040063704A1 (en) 2004-04-01
KR20030051747A (ko) 2003-06-25
EP1330460A2 (en) 2003-07-30
JP4242643B2 (ja) 2009-03-25

Similar Documents

Publication Publication Date Title
NO20031838L (no) Benzoksazinonderivater, deres fremstilling av anvendelse
NO20030134D0 (no) Fremstilling av olefinderivater
NO20024742L (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20013945D0 (no) Fremstilling av isoflavonderivater
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20024749D0 (no) Indolin-2-on-derivater, deres fremstilling og anvendelse som ocytocin reseptor ligander
NO20032234L (no) Nye imidazolderivater, deres fremstilling og anvendelse
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
DE50114491D1 (de) Substituierte C-Cyclohexylmethylamin-Derivative
DE60142051D1 (de) Herstellung von perfluorolefinen
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
NO20024707D0 (no) Fremstilling av diacetaler av glyoksal
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
FI20002526A0 (fi) Pyridatsinonijohdannaisten uusi käyttö
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater